Research map: Evaluation of a Novel Peptide‐Based ELISA for the Serological Diagnosis of Trypanosoma cruzi Infection

Back to the article

Papers in this map

  1. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI · Bianca Silvana Zingales · 2009 · 1063 citations · Cited by this paper
  2. Human Pharmacokinetic Prediction of Antibody‐Drug Conjugates Using Human FcRn Transgenic Mice · 2026 · Related
  3. Chagas disease: A Latin American health problem becoming a world health problem · Gabriel A. Schmuñis · 2009 · 860 citations · Cited by this paper
  4. From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial Diseases · 2026 · Related
  5. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction · David J. Moser · 1989 · 425 citations · Cited by this paper
  6. Deep‐Learning: An Emerging Tool to Support Model‐Informed Drug Development · 2026 · Related
  7. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity · Bianca Silvana Zingales · 2017 · 398 citations · Cited by this paper
  8. CYP2C19 c. 681G >A Is not in Complete Linkage Disequilibrium With c.332‐ 23A >G: Implications for Pharmacogenetic Testing · 2026 · Related
  9. Use of a Simplified Polymerase Chain Reaction Procedure to Detect Trypanosoma cruzi in Blood Samples from Chronic Chagasic Patients in a Rural Endemic Area · Patrick Wincker · 1994 · 286 citations · Cited by this paper
  10. A Generative AI Framework for Pharmacokinetic Clinical Study Report Authoring · 2026 · Related
  11. A Systematic Review of High Quality Diagnostic Tests for Chagas Disease · Anna M. Afonso · 2012 · 101 citations · Cited by this paper
  12. Model‐Informed Development of a Subcutaneous Formulation of Tislelizumab: Phase 1 Pharmacokinetics in Patients With Cancer · 2026 · Related
  13. Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment · Analı́a Porrás · 2015 · 91 citations · Cited by this paper
  14. Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA / EMA · 2026 · Related
  15. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic · Daniel Guzmán‐Gómez · 2015 · 85 citations · Cited by this paper
  16. Drug Interactions of Vebreltinib, a Novel Type I c‐Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants · 2026 · Related
  17. Congenital Transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: An Observational Prospective Study · Pierre M Buekens · 2017 · 77 citations · Cited by this paper
  18. Anti‐ PEG Antibodies From mRNA COVID ‐19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels · 2026 · Related
  19. Geographic Variations in Test Reactivity for the Serological Diagnosis of Trypanosoma cruzi Infection · Carine Truyens · 2021 · 69 citations · Cited by this paper
  20. Assessing Trypanosoma cruzi Parasite Diversity through Comparative Genomics: Implications for Disease Epidemiology and Diagnostics · Alicia Majeau · 2021 · 51 citations · Cited by this paper
  21. Retrospect, advances and challenges in Chagas disease diagnosis: a comprehensive review · Alejandro Gabriel Schijman · 2024 · 46 citations · Cited by this paper
  22. Serodiscordance in chronic Chagas disease diagnosis: a real problem in non-endemic countries · Zaira Moure · 2016 · 45 citations · Cited by this paper
  23. Phylogenetic Analysis of Trypanosoma cruzi from Pregnant Women and Newborns from Argentina, Honduras, and Mexico Suggests an Association of Parasite Haplotypes with Congenital Transmission of the Parasite · Claudia Patricia Herrera · 2019 · 36 citations · Cited by this paper
  24. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 · Ewerton Cousin · 2025 · 35 citations · Cited by this paper
  25. The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas · Alejandro D. Ricci · 2023 · 34 citations · Cited by this paper
  26. Definition of a diagnostic routine in individuals with inconclusive serology for chagas disease · Mariele Cristina Modolo Picka · 2007 · 25 citations · Cited by this paper
  27. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas’ disease · Rutyanne Maria Tonelli Elisei · 2018 · 24 citations · Cited by this paper
  28. Genome-Wide Screening and Identification of New Trypanosoma cruzi Antigens with Potential Application for Chronic Chagas Disease Diagnosis · João Luís Reis-Cunha · 2014 · 22 citations · Cited by this paper
  29. Identification of highly conserved Trypanosoma cruzi antigens for the development of a universal serological diagnostic assay · Alicia Majeau · 2024 · 22 citations · Cited by this paper
  30. A Multi-Epitope Protein for High-Performance Serodiagnosis of Chronic Chagas Disease in ELISA and Lateral Flow Platforms · Evandro R. Dias · 2024 · 8 citations · Cited by this paper
  31. Simplifying screening for Trypanosoma cruzi in pregnant persons and their infants · Pierre M Buekens · 2023 · 6 citations · Cited by this paper
  32. Diagnosis of Trypanosoma cruzi infection in Mexican populations: current conventional serology lacks adequate sensitivity and specificity · Janine M. Ramsey · 2025 · 5 citations · Cited by this paper
  33. Comparison between chimeric Trypanosoma cruzi antigens (ABBOTT PRISM Chagas assay) and local antigenic extracts in blood bank screening for Chagas disease in an endemic area for the Triatoma dimidiata vector · Floribeth León Pérez · 2025 · 3 citations · Cited by this paper
  34. A Trypanosoma cruzi Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin America · Hannah M. Kortbawi · 2025 · 3 citations · Cited by this paper
  35. Diagnostic Performance of Chimeric Recombinant Antigens of Trypanosoma cruzi for Identifying Chagas Disease in Samples From Rio Grande do Sul · Ângelo Antônio Oliveira Silva · 2025 · 2 citations · Cited by this paper
  36. Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala · Karla J. Lange · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)